This inventor holds 2 USPTO granted patents. Top assignee: Fujitsu Corporation. Active years: 1999-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2004
Title: Innovations of Kensaku Imai in DNA Sequencing Technology
Introduction
Kensaku Imai is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of DNA sequencing technology. With a total of 2 patents, his work focuses on improving the precision and efficiency of DNA manipulation processes.
Latest Patents
One of Imai's latest patents is a "Method and apparatus for automatically removing vector unit in DNA base sequence." This invention aims to enhance the cloning process by precisely removing vector unit base sequences from integrated DNA. The method generates a retrieval key based on the vector and restriction enzyme used, allowing for accurate identification and removal of unwanted sequences.
Another significant patent is the "Method and device for fragment trace data display in DNA base sequencing." This invention addresses the challenge of editing base sequences in consensus sequences obtained from DNA fragments. It enables the identification and display of specific traces corresponding to the base sequences that require editing, thereby facilitating more efficient DNA analysis.
Career Highlights
Kensaku Imai is currently employed at Fujitsu Corporation, where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in genetic research and medical diagnostics.
Collaborations
Imai collaborates with Masato Kitajima, contributing to advancements in DNA sequencing technologies. Their partnership exemplifies the importance of teamwork in driving innovation in scientific research.
Conclusion
Kensaku Imai's contributions to DNA sequencing technology through his patents demonstrate his commitment to advancing the field. His innovative methods have the potential to significantly impact genetic research and biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
